Health Trials

Solid Tumor and Lymphoma

1

Review clinical trials related to Solid Tumor and Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

The study will consist of a Phase I dose-escalation and Phase IIa dose-expansion component. Phase I dose-escalation phase will establish the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D),and evaluate the preliminary antitumor activity of HX111.

Participants needed: 70
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Hanx Biopharmaceuticals (Wuhan) Co., Ltd.Updated: Jan 13, 2026
Eligibility criteria

1. Able to understand and voluntarily sign the Informed Consent Form (ICF); 2. M... [+8]

1. Prior malignancy active within the previous 2 years except for the tumor for... [+3]

Read more